Outcomes at 3-Years in EBV+ Recipients of Deceased Donor Kidneys From Two Randomized Trials (BENEFIT and BENEFIT EXT) Comparing Belatacept vs Cyclosporine.
Muehlbacher, F., Durrbach, A., Florman, S., Pestana, Medina J., Harler, M., Larsen, C.Volume:
98
Journal:
Transplantation
DOI:
10.1097/00007890-201407151-01513
Date:
July, 2014
File:
PDF, 179 KB
2014